Image Source: ChiniMandi
In a big move to assist the pharma sector, the government of India has stated that pharma-grade sugar exporters can export as much as 25,000 metric tons (MT) of sugar a financial year if they receive a restricted export authorisation. The policy, issued by the Directorate General of Foreign Trade (DGFT), is meant to assist legitimate pharma exporters meet international demand without sacrificing quality standards in the domestic market.
Pharma-grade sugar, which is extremely pure and meets stringent production quality, is among the key ingredients of most pharmaceutical formulations. The new quota of exports will likely be a relief to sugar mills and refiners, most of whom have been fighting inventory build-up and fluctuating domestic demand.
Key Highlights
Export Quota: Export by bona fide drug exporters of up to 25,000 MT pharma-grade sugar in a financial year on limited export authorization.
Quality Focus: Only pharma-grade sugar produced to certain standards is acceptable, which guarantees international competitiveness and safety.
Electronic Facilitation: DGFT launched the 'Source from India' facility in its Trade Connect ePlatform, which allowed exporters to showcase products and credentials to international buyers and thereby facilitate trade discovery and engagement.
Sectoral Influence: The step is likely to relieve financial stress on sugar mills, facilitate cane arrears clearance, and be in line with industry hopes for increased export opportunities in the backdrop of high closing inventories.
Wider Context: Overall sugar exports are maintained within limits to sustain domestic prices, but this particular concession is meant to benefit the value-added and pharmaceutical industries.
This policy is viewed as a strategic move in reconciling domestic supply bottlenecks with the necessity to increase pharmaceutical exports and promote allied industries.
Source: Devdiscourse, Economic Times, Rediff Money
Advertisement
Advertisement